RECRUITING

Transcranial Magnetic Stimulation in Misophonia

Talk to us

Conditions

MisophoniaTranscranial Magnetic StimulationCrossover trialSingle sessionEEG

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of the project is to assess the efficacy of parietal transcranial magnetic stimulation in misophonia. N=60 participants will undergo two transcranial magnetic stimulation sessions: one inhibitory and another excitatory. During both sessions, the parietal region will be stimulated. Participants will perform computerized tasks immediately before and after the stimulation, while EEG, heart rate, and skin temperature will be recorded. These recordings will be used to assess if TMS can be used to improve tolerance to misophonia triggers.

Official Title

A Transcranial Magnetic Stimulation Approach to Treat Misophonia

Quick Facts

Study Start:2025-08-27
Study Completion:2026-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06960083

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 55 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Hypersensitive to presence of a specific sound, which may be accompanied by irritation, anger/outbursts, or fear.
  2. * Must be between the ages of 18 - 55.
  3. * Must be fluent in English since the study's instructions, surveys, and tasks will be in English.
  1. * Axis I Psychiatric condition, past or present, as defined in DSM-V.
  2. * Disability or medical condition that prohibits completion of study. Participants must be able to complete all study procedures to ensure optimal conditions for data analysis.
  3. * Central Nervous System (CNS) disease, such as history of brain abnormalities (e.g., neoplasms, subarachnoid cysts), cerebrovascular disease, infectious disease (e.g., abscess), or other neurological diseases, history of head trauma (defined as loss of consciousness\>3 min), or history of seizures without a resolved etiology. CNS disease and drugs that act in the peripheral or central nervous system are likely to have effects on patterns of neural activity.
  4. * Recent or regular use of psychotropic medication (e.g., amitriptyline for migraines).
  5. * Recent use of drugs of abuse.
  6. * Presence of any mental implants in the head.
  7. * Pregnant or lactating.

Contacts and Locations

Study Contact

Shama Patel
CONTACT
347-670-4878
shama.patel@mssm.edu
Parul Jain, PhD
CONTACT
212-824-8992
parul.jain@mssm.edu

Principal Investigator

Parul Jain, PhD
PRINCIPAL_INVESTIGATOR
Icahn School of Medicine at Mount Sinai

Study Locations (Sites)

Mount Sinai West
New York, New York, 10022
United States

Collaborators and Investigators

Sponsor: Icahn School of Medicine at Mount Sinai

  • Parul Jain, PhD, PRINCIPAL_INVESTIGATOR, Icahn School of Medicine at Mount Sinai

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-08-27
Study Completion Date2026-06-30

Study Record Updates

Study Start Date2025-08-27
Study Completion Date2026-06-30

Terms related to this study

Keywords Provided by Researchers

  • Misophonia
  • Transcranial Magnetic Stimulation
  • Crossover trial
  • Single session
  • EEG

Additional Relevant MeSH Terms

  • Misophonia